HEMGENIX
These highlights do not include all the information needed to use HEMGENIX safely and effectively. See full prescribing information for HEMGENIX. HEMGENIX (etranacogene dezaparvovec-drlb) suspension, for intravenous infusion Initial U.S. Approval: 2022
35b2db65-4c6c-4173-ab56-b2bca69193bd
HUMAN PRESCRIPTION DRUG LABEL
May 4, 2023
CSL Behring
DUNS: 058268293
Products 10
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
etranacogene dezaparvovec
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
etranacogene dezaparvovec
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
etranacogene dezaparvovec
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
etranacogene dezaparvovec
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
etranacogene dezaparvovec
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
etranacogene dezaparvovec
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
etranacogene dezaparvovec
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
etranacogene dezaparvovec
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
etranacogene dezaparvovec
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
etranacogene dezaparvovec
Product Details
FDA regulatory identification and product classification information